-
Mazagon Dock
3,149.70 3,047.00(%) -
Reliance Industr
1,411.85 1,608.95(%) -
Garden Reach Sh.
1,855.00 890.05(%) -
Bajaj Finance
8,560.00 6,376.55(%) -
Cochin Shipyard
1,600.40 1,169.00(%) -
Torrent Pharma.
3,360.00 3,589.95(%) -
Hind.Aeronautics
4,466.00 3,045.95(%) -
Tata Motors
641.10 542.55(%) -
Paras Defence
1,469.00 1,592.75(%) -
Samvardh. Mothe.
131.75 107.30(%) -
Data Pattern
2,459.05 1,350.50(%) -
Varun Beverages
507.45 419.40(%) -
IndusInd Bank
810.40 605.40(%) -
Trent
5,134.00 4,058.45(%) -
Bharat Electron
312.50 221.00(%) -
Hitachi Energy
14,879.00 16,534.50(%) -
ICICI Bank
1,424.00 1,051.50(%) -
Sonata Software
415.25 762.00(%) -
Tech Mahindra
1,510.60 1,807.40(%) -
HDFC Bank
1,936.40 1,977.95(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aarti Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs
- Alchemie Group
- BSE Code : 2975.0
- ISIN : INE767A01016
-
Today’s Low
348.80 -
Today’s High
360.00

-
Open
354.30 -
Perv Close
351.65 -
52W Low
312.00 -
52W High
635.00
Key Indicators
-
P/E(TTM)
24.48
-
Mar.Cap (₹Cr.)
3,225.08
-
Div & Yield %
0.28
-
Book Value(₹)
126.18
-
Debt-Equity Ratio
-0.24
-
AGM Date
29-Apr-2025
-
EPS
14.35
-
P/E Ratio
24.48
Financials Ratios
-
Debt-Equity Ratio
0.47
-
Mar.Cap (₹Cr.)
3,225.08
-
RONW (%)
13.87
-
ROCE (%)
14.97
Score Board
-
Equity (₹ in Cr.)
91.94
-
BV (₹)
126.20
-
Sales( ₹ in Cr.)
2,266.91
-
NP (in Cr.)
141.88
-
NP Var(%)
-7.0
-
Div%
10.0
-
CPS (₹)
20.60
-
EPS (₹)
15.40
-
Traded Value (₹ in Lakhs)
3,230.14
-
52 Week High
635.00
-
52 Week Low
312.00
-
Price BSE
351.0
-
Price NSE
351.00
-
Market Capital( in Cr.)
3,230.14
-
P/C Ratio
17.00
-
P/E Ratio
22.70
-
Price Vs.BV
15.40
-
30-Apr-2025( 11:38)
Corporate News - Aarti... - Aarti Drugs will hold a meetin...
-
31-Jan-2025( 07:10)
Corporate News - Aarti... - Aarti Drugs has received reaff...
-
30-Jan-2025( 12:14)
Hot Pursuit - Aarti... - Revenue from operations declin...
-
29-Jan-2025( 05:03)
Corporate News - Board... - Aarti Drugs announced that the...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 2,266.91 | 2,497.97 | 2,251.17 | 1,914.89 | 1,634.92 | 1,454.25 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 2,266.91 | 2,497.97 | 2,251.17 | 1,914.89 | 1,634.92 | 1,454.25 |
Other Income | 4.18 | 2.23 | 4.77 | 9.69 | 9.44 | 6.28 |
Stock Adjustments | -26.77 | 6.72 | 77.94 | 9.08 | 53.94 | -19.05 |
Total Income | 2,244.32 | 2,506.92 | 2,333.88 | 1,933.66 | 1,698.30 | 1,441.48 |
EXPENDITURE : | ||||||
Raw Materials | 1,476.42 | 1,723.25 | 1,558.47 | 1,148.99 | 1,099.82 | 945.98 |
Power and Fuel Cost | 151.64 | 153.45 | 126.05 | 95.64 | 101.04 | 82.14 |
Employee Cost | 70.20 | 64.30 | 57.17 | 55.60 | 52.65 | 47.23 |
Other Manufacturing Expenses | 191.24 | 182.71 | 171.26 | 138.99 | 122.62 | 103.91 |
Selling and Administration Expenses | 73.95 | 89.25 | 89.75 | 76.70 | 59.39 | 50.37 |
Miscellaneous Expenses | 7.52 | 5.68 | 5.24 | 6.72 | 5.40 | 2.83 |
Employee Benefit Expenses | 70.20 | 64.30 | 57.17 | 55.60 | 52.65 | 47.23 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,970.96 | 2,218.64 | 2,007.95 | 1,522.64 | 1,440.92 | 1,232.46 |
Operating Profit | 273.36 | 288.28 | 325.94 | 411.02 | 257.38 | 209.02 |
Interest | 33.21 | 36.18 | 23.05 | 25.71 | 35.74 | 41.00 |
Gross Profit | 240.15 | 252.10 | 302.89 | 385.31 | 221.64 | 168.02 |
Depreciation | 47.67 | 47.29 | 47.39 | 47.60 | 46.67 | 40.39 |
Profit Before Tax | 192.48 | 204.81 | 255.50 | 337.71 | 174.97 | 127.63 |
Current Tax | 49.60 | 53.25 | 65.50 | 84.50 | 49.55 | 31.92 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 1.00 | -1.25 | -5.00 | -4.50 | -10.25 | 8.45 |
Reported Net Profit | 141.88 | 152.81 | 195.00 | 257.71 | 135.67 | 87.26 |
Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.17 | 6.35 | 2.54 |
Adjusted Net Profit | 141.88 | 152.81 | 195.00 | 257.54 | 129.32 | 84.72 |
Adjustment below Net Profit | -13.32 | 0.00 | -51.64 | -69.90 | -26.90 | -0.48 |
P & L Balance brought forward | 947.13 | 818.86 | 704.26 | 565.52 | 475.07 | 399.36 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 23.38 | 24.54 | 28.76 | 49.07 | 18.32 | 11.06 |
P & L Balance carried down | 1,052.31 | 947.13 | 818.86 | 704.26 | 565.52 | 475.07 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 10.00 | 10.00 | 10.00 | 25.00 | 20.00 | 10.00 |
Dividend Per Share(Rs) | 1.00 | 1.00 | 1.00 | 2.50 | 2.00 | 1.00 |
Earnings Per Share-Unit Curr | 15.43 | 16.50 | 21.06 | 27.65 | 58.23 | 37.00 |
Earnings Per Share(Adj)-Unit Curr | 15.43 | 16.50 | 21.06 | 27.65 | 14.56 | 9.25 |
Book Value | 127.83 | 120.34 | 104.99 | 92.23 | 266.86 | 219.90 |
Book Value(Adj)-Unit Curr | 127.83 | 120.34 | 104.99 | 92.23 | 66.72 | 54.97 |